PubMed

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.

Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE.

Br J Haematol. 2009 Nov 6. [Epub ahead of print]PMID: 19895615 [PubMed - as supplied by publisher]Related articles

Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.

Zent CS, Ding W, Reinalda MS, Schwager SM, Hoyer JD, Bowen DA, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Kay NE, Slager SL.

Leuk Lymphoma. 2009 Aug;50(8):1261-8.PMID: 19811329 [PubMed - in process]Related articles

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

Ding W, Nowakowski GS, Knox TR, Boysen JC, Maas ML, Schwager SM, Wu W, Wellik LE, Dietz AB, Ghosh AK, Secreto CR, Medina KL, Shanafelt TD, Zent CS, Call TG, Kay NE.

Br J Haematol. 2009 Nov;147(4):471-83. Epub 2009 Sep 8.PMID: 19751240 [PubMed - in process]Related articles

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.

Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA.

J Clin Oncol. 2009 Aug 20;27(24):3959-63. Epub 2009 Jul 20.PMID: 19620484 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.

Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, Secreto CR, Ghosh AK, Kabat BF, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE.

J Clin Oncol. 2009 Aug 10;27(23):3808-14. Epub 2009 May 26.PMID: 19470922 [PubMed - indexed for MEDLINE]Related articles

N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia.

Kay NE, Shanafelt TD, Call TG, Wu W, Laplant BR.

Leuk Lymphoma. 2009 Apr;50(4):588-92.PMID: 19373657 [PubMed - indexed for MEDLINE]Related articles

Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.

Cerhan JR, Novak AJ, Fredericksen ZS, Wang AH, Liebow M, Call TG, Dogan A, Witzig TE, Ansell SM, Habermann TM, Kay NE, Slager SL.

Br J Haematol. 2009 Jun;145(5):614-23. Epub 2009 Mar 30.PMID: 19344414 [PubMed - indexed for MEDLINE]Related articles

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.

Nowakowski GS, Hoyer JD, Shanafelt TD, Zent CS, Call TG, Bone ND, Laplant B, Dewald GW, Tschumper RC, Jelinek DF, Witzig TE, Kay NE.

J Clin Oncol. 2009 Apr 10;27(11):1844-9. Epub 2009 Mar 2.PMID: 19255329 [PubMed - indexed for MEDLINE]Related articles

Validation of a new prognostic index for patients with chronic lymphocytic leukemia.

Shanafelt TD, Jenkins G, Call TG, Zent CS, Slager S, Bowen DA, Schwager S, Hanson CA, Jelinek DF, Kay NE.

Cancer. 2009 Jan 15;115(2):363-72.PMID: 19090008 [PubMed - indexed for MEDLINE]Related articles

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.

Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA.

Blood. 2009 Apr 30;113(18):4188-96. Epub 2008 Nov 17.PMID: 19015397 [PubMed - indexed for MEDLINE]Related articles

Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.

Awan FT, Kay NE, Davis ME, Wu W, Geyer SM, Leung N, Jelinek DF, Tschumper RC, Secreto CR, Lin TS, Grever MR, Shanafelt TD, Zent CS, Call TG, Heerema NA, Lozanski G, Byrd JC, Lucas DM.

Blood. 2009 Jan 15;113(3):535-7. Epub 2008 Nov 13.PMID: 19008456 [PubMed - indexed for MEDLINE]Related articles

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3161-9.PMID: 18990758 [PubMed - indexed for MEDLINE]Related articlesFree article

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.

Zent CS, Call TG, Shanafelt TD, Tschumper RC, Jelinek DF, Bowen DA, Secreto CR, Laplant BR, Kabat BF, Kay NE.

Cancer. 2008 Oct 15;113(8):2110-8.PMID: 18759253 [PubMed - indexed for MEDLINE]Related articlesFree article

The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia.

Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG.

Leuk Res. 2009 Feb;33(2):263-70. Epub 2008 Jul 25.PMID: 18656259 [PubMed - indexed for MEDLINE]Related articles

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.

Zent CS, Secreto CR, LaPlant BR, Bone ND, Call TG, Shanafelt TD, Jelinek DF, Tschumper RC, Kay NE.

Leuk Res. 2008 Dec;32(12):1849-56. Epub 2008 Jun 27.PMID: 18584865 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM, Markovic SN, Call TG, Bowen DA, Jelinek DF, Kay NE, Shanafelt TD.

Br J Haematol. 2008 May;141(5):607-14. Epub 2008 Apr 1.PMID: 18384436 [PubMed - indexed for MEDLINE]Related articles

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.

Zent CS, Ding W, Schwager SM, Reinalda MS, Hoyer JD, Jelinek DF, Tschumper RC, Bowen DA, Call TG, Shanafelt TD, Kay NE, Slager SL.

Br J Haematol. 2008 May;141(5):615-21. Epub 2008 Mar 27.PMID: 18373706 [PubMed - indexed for MEDLINE]Related articlesFree article

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE.

Br J Haematol. 2008 Mar;140(5):537-46.PMID: 18275431 [PubMed - indexed for MEDLINE]Related articles

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA.

Leuk Res. 2008 Sep;32(9):1458-61. Epub 2008 Jan 7.PMID: 18179821 [PubMed - indexed for MEDLINE]Related articlesFree article

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features.

Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD.

Leuk Lymphoma. 2007 Dec;48(12):2412-7.PMID: 18067017 [PubMed - indexed for MEDLINE]Related articles

Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.

Tschumper RC, Geyer SM, Campbell ME, Kay NE, Shanafelt TD, Zent CS, Nowakowski GS, Call TG, Dewald GW, Jelinek DF.

J Clin Invest. 2008 Jan;118(1):306-15.PMID: 18064298 [PubMed - indexed for MEDLINE]Related articlesFree article

Susceptibility genes and B-chronic lymphocytic leukaemia.

Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR.

Br J Haematol. 2007 Dec;139(5):762-71. Review.PMID: 18021089 [PubMed - indexed for MEDLINE]Related articles

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

Maddocks-Christianson K, Slager SL, Zent CS, Reinalda M, Call TG, Habermann TM, Bowen DA, Hoyer JD, Schwager S, Jelinek DF, Kay NE, Shanafelt TD.

Br J Haematol. 2007 Nov;139(3):398-404.PMID: 17910629 [PubMed - indexed for MEDLINE]Related articles

Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.

Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Sloan JA, Call TG.

Br J Haematol. 2007 Oct;139(2):255-64.PMID: 17897301 [PubMed - indexed for MEDLINE]Related articles

Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL.

Blood. 2007 Dec 15;110(13):4455-63. Epub 2007 Sep 7.PMID: 17827388 [PubMed - indexed for MEDLINE]Related articlesFree article

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.

Sellick GS, Goldin LR, Wild RW, Slager SL, Ressenti L, Strom SS, Dyer MJ, Mauro FR, Marti GE, Fuller S, Lyttelton M, Kipps TJ, Keating MJ, Call TG, Catovsky D, Caporaso N, Houlston RS.

Blood. 2007 Nov 1;110(9):3326-33. Epub 2007 Aug 8.PMID: 17687107 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia.

Browning RL, Geyer SM, Johnson AJ, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Zent CS, Bone ND, Dewald GW, Lin TS, Heerema NA, Grever MR, Kay NE, Byrd JC, Lucas DM.

Leuk Res. 2007 Dec;31(12):1737-40. Epub 2007 Jul 19.PMID: 17659340 [PubMed - indexed for MEDLINE]Related articlesFree article

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.

Nowakowski GS, Hoyer JD, Shanafelt TD, Geyer SM, LaPlant BR, Call TG, Jelinek DF, Zent CS, Kay NE.

Mayo Clin Proc. 2007 Apr;82(4):449-53.PMID: 17418074 [PubMed - indexed for MEDLINE]Related articlesFree article

Update on risk-stratified management for chronic lymphocytic leukemia.

Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE.

Leuk Lymphoma. 2006 Sep;47(9):1738-46. Review.PMID: 17064983 [PubMed - indexed for MEDLINE]Related articles

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW.

J Clin Oncol. 2006 Oct 1;24(28):4634-41.PMID: 17008705 [PubMed - indexed for MEDLINE]Related articles

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.

Kay NE, Geyer SM, Call TG, Shanafelt TD, Zent CS, Jelinek DF, Tschumper R, Bone ND, Dewald GW, Lin TS, Heerema NA, Smith L, Grever MR, Byrd JC.

Blood. 2007 Jan 15;109(2):405-11. Epub 2006 Sep 28.PMID: 17008537 [PubMed - indexed for MEDLINE]Related articlesFree article

Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia.

Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE.

Ann Intern Med. 2006 Sep 19;145(6):435-47. Review.PMID: 16983131 [PubMed - indexed for MEDLINE]Related articlesFree article

Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study.

Miller RC, Villà S, Kamer S, Pasquier D, Poortmans P, Micke O, Call TG.

Radiother Oncol. 2006 Sep;80(3):323-6. Epub 2006 Sep 7.PMID: 16959346 [PubMed - indexed for MEDLINE]Related articles

Absolute lymphocyte count predicts overall survival in follicular lymphomas.

Siddiqui M, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN, Johnston PB, Call TG, Porrata LF.

Br J Haematol. 2006 Sep;134(6):596-601. Epub 2006 Aug 1.PMID: 16889618 [PubMed - indexed for MEDLINE]Related articles

Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia.

Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW.

Cancer Genet Cytogenet. 2006 Jun;167(2):177-81.PMID: 16737921 [PubMed - indexed for MEDLINE]Related articles

Views of new internal medicine faculty of their preparedness and competence in physician-patient communication.

Mueller PS, Barrier PA, Call TG, Duncan AK, Hurley DL, Multari A, Rabatin JT, Li JT.

BMC Med Educ. 2006 May 26;6:30.PMID: 16729886 [PubMed - indexed for MEDLINE]Related articlesFree article

Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.

Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW.

Cancer Genet Cytogenet. 2006 Apr 15;166(2):152-6.PMID: 16631472 [PubMed - indexed for MEDLINE]Related articles

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM.

J Clin Oncol. 2006 Feb 20;24(6):983-7. Epub 2006 Jan 23.PMID: 16432079 [PubMed - indexed for MEDLINE]Related articles

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.

Shanafelt TD, Lee YK, Call TG, Nowakowski GS, Dingli D, Zent CS, Kay NE.

Leuk Res. 2006 Jun;30(6):707-12. Epub 2005 Dec 1.PMID: 16325256 [PubMed - indexed for MEDLINE]Related articles

Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.

Nowakowski GS, Dewald GW, Hoyer JD, Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED, Phyliky RL, Call TG, Shanafelt TD, Kay NE, Zent CS.

Br J Haematol. 2005 Jul;130(1):36-42.PMID: 15982342 [PubMed - indexed for MEDLINE]Related articles

Clinical significance of monoclonal B cells in cerebrospinal fluid.

Nowakowski GS, Call TG, Morice WG, Kurtin PJ, Cook RJ, Zent CS.

Cytometry B Clin Cytom. 2005 Jan;63(1):23-7.PMID: 15624205 [PubMed - indexed for MEDLINE]Related articlesFree article

Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.

Ghobrial IM, Uslan DZ, Call TG, Witzig TE, Gertz MA.

Am J Hematol. 2004 Dec;77(4):329-30.PMID: 15551276 [PubMed - indexed for MEDLINE]Related articles

Current approach to diagnosis and management of chronic lymphocytic leukemia.

Shanafelt TD, Call TG.

Mayo Clin Proc. 2004 Mar;79(3):388-98. Review.PMID: 15008611 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.

Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, James CD, Jelinek DF, Tschumper RC, Hanson CA, Pruthi RK, Witzig TE, Call TG, Kay NE.

Br J Haematol. 2003 Apr;121(2):287-95.PMID: 12694251 [PubMed - indexed for MEDLINE]Related articles

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.

Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH.

Blood. 2002 May 15;99(10):3854-6.PMID: 11986248 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Mesa RA, Tefferi A, Elliott MA, Hoagland HC, Call TG, Schroeder GS, Yoon SY, Li CY, Gray LA, Margolin S, Hook CC.

Br J Haematol. 2001 Jul;114(1):111-3.PMID: 11472354 [PubMed - indexed for MEDLINE]Related articles

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.

Tefferi A, Elliot MA, Yoon SY, Li CY, Mesa RA, Call TG, Dispenzieri A.

Blood. 2001 Mar 15;97(6):1896. No abstract available. PMID: 11263440 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombocytopenia after iron dextran administration in a patient with severe iron deficiency anemia.

Go RS, Porrata LF, Call TG.

Ann Intern Med. 2000 Jun 6;132(11):925. No abstract available. PMID: 10836930 [PubMed - indexed for MEDLINE]Related articlesFree article

Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications.

Go RS, Call TG.

Mayo Clin Proc. 2000 Jan;75(1):83-5. Review.PMID: 10630762 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant disease.

Call TG, Creagan ET, Frytak S, Buckner JC, van Haelst-Pisani C, Homburger HA, Katzmann JA.

Am J Clin Oncol. 1994 Aug;17(4):344-7.PMID: 8048398 [PubMed - indexed for MEDLINE]Related articles